Vimpat and Oesophagitis aggravated - a phase IV clinical study of FDA data

Summary:

Oesophagitis aggravated is reported only by a few people who take Vimpat.

The phase IV clinical study analyzes which people take Vimpat and have Oesophagitis aggravated. It is created by eHealthMe based on reports of 17,280 people who have side effects while taking Vimpat from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

17,280 people reported to have side effects when taking Vimpat.
Among them, 2 people (0.01%) have Oesophagitis aggravated.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 17,800 Vimpat users for its effectiveness, alternative drugs and more.

What is Oesophagitis aggravated?

Oesophagitis aggravated (worse inflammation of oesophagus) is found to be associated with 941 drugs and 292 conditions by eHealthMe.

Number of Vimpat and Oesophagitis aggravated reports submitted per year:

Could Vimpat cause Oesophagitis aggravated?

Gender of people who have Oesophagitis aggravated when taking Vimpat *:

female: 100 %
male: 0.0 %

Common drugs people take besides Vimpat *:

Common side effects people have besides Oesophagitis aggravated *:

Weakness: 1 person, 50.00%
Headache (pain in head): 1 person, 50.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 50.00%
Gait Disturbance: 1 person, 50.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 50.00%
Fatigue (feeling of tiredness): 1 person, 50.00%
Eye Movement Disorder: 1 person, 50.00%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 50.00%
Excessive Eye Blinking (excessive blinking is dry eyes): 1 person, 50.00%
Emotional Disorder: 1 person, 50.00%

Common conditions people have *:

Nausea (feeling of having an urge to vomit): 1 person, 50.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vimpat and have Oesophagitis aggravated?

Check whether Oesophagitis aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Oesophagitis aggravated and when was it recovered:

Oesophagitis aggravated in Vimpat

Expand to all the drugs that have ingredients of lacosamide:

Oesophagitis aggravated and drugs with ingredients of lacosamide

Alternative drugs to, pros and cons of Vimpat:

Vimpat (17,800 reports)

Common Vimpat side effects:

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oesophagitis aggravated treatments and more:

Oesophagitis aggravated (34 reports)

COVID vaccines that are related to Oesophagitis aggravated:

Common drugs associated with Oesophagitis aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide (the active ingredients of Vimpat) and Vimpat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.